December 10, 2012

ISIS: Keep an Eye

ISIS Pharmaceuticals, a drug company that is working on Antinsense technology (a new platform of treatment) is picking up some new momentum. (Y! Finance Ticker)

The company has had some interesting spin offs (Ibis - bought by Abbott) . So, it is worth keeping an eye incase Biogen or another large cap biopharma decides to gobble up ISIS.

This is not a recommendation, but just an intelligent guess.

Good luck.

past posts on ISIS are here.

Join the Discussion